Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2006, Article ID 97287, 17 pages
http://dx.doi.org/10.1155/JBB/2006/97287
Research Article

6A3-5/Osa2 is an Early Activated Gene Implicated in the Control of Vascular Smooth Muscle Cell Functions

1INSERM XR331, Faculté of Médicine Laënnec, Lyon 69372, France
2Genomics and Atherothrombosis, Thrombosis Research Institute, London SW3 6LR, UK
3Département de Physiologie et Pharmacologie Clinique, Faculté de Pharmacie, Université Lyon 1, Lyon, France
4Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht, The Netherlands
5Center for Cardiovascular Biology and Medicine, King's College, University of London, UK

Received 17 April 2006; Revised 11 July 2006; Accepted 17 July 2006

Copyright © 2006 Gwenaele Garin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R Ross, “The pathogenesis of atherosclerosis: a perspective for the 1990s,” Nature, vol. 362, no. 6423, pp. 801–809, 1993. View at Publisher · View at Google Scholar
  2. S M Schwartz, G R Campbell, and J H Campbell, “Replication of smooth muscle cells in vascular disease,” Circulation Research, vol. 58, no. 4, pp. 427–444, 1986. View at Google Scholar
  3. A D Hughes, G F Clunn, J Refson, and C Demoliou-Mason, “Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle,” General Pharmacology, vol. 27, no. 7, pp. 1079–1089, 1996. View at Publisher · View at Google Scholar
  4. M J Daemen, D M Lombardi, F T Bosman, and S M Schwartz, “Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall,” Circulation Research, vol. 68, no. 2, pp. 450–456, 1991. View at Google Scholar
  5. R M Touyz, “The role of angiotensin II in regulating vascular structural and functional changes in hypertension,” Current Hypertension Reports, vol. 5, no. 2, pp. 155–164, 2003. View at Google Scholar
  6. R V Sharma and R C Bhalla, “PDGF-induced mitogenic signaling is not mediated through protein kinase C and c-fos pathway in VSM cells,” American Journal of Physiology, vol. 264, no. 1 pt 1, pp. C71–C79, 1993. View at Google Scholar
  7. A Hultgardh-Nilsson, B Cercek, J-W Wang et al., “Regulated expression of the Ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro,” Circulation Research, vol. 78, no. 4, pp. 589–595, 1996. View at Google Scholar
  8. K Brand, S Page, G Rogler et al., “Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion,” Journal of Clinical Investigation, vol. 97, no. 7, pp. 1715–1722, 1996. View at Google Scholar
  9. K K Griendling and R W Alexander, “Cellular mechanisms of angiotensin II action,” in Textbook of Hypertension, J D Swales, Ed., pp. 244–253, Blackwell, Oxford, UK, 1994. View at Google Scholar
  10. K Zibara, G Garin, and J L McGregor, “Identification, structural, and functional characterization of a new early gene (6A3-5,7 kb): implication in the proliferation and differentiation of smooth muscle cells,” Journal of Biomedicine and Biotechnology, vol. 2005, no. 3, pp. 254–270, 2005. View at Publisher · View at Google Scholar
  11. D Wilsker, A Patsialou, P B Dallas, and E Moran, “ARID proteins: a diverse family of DNA binding proteins implicated in the control of cell growth, differentiation, and development,” Cell Growth and Differentiation, vol. 13, no. 3, pp. 95–106, 2002. View at Google Scholar
  12. S L Gregory, R D Kortschak, B Kalionis, and R Saint, “Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins,” Molecular and Cellular Biology, vol. 16, no. 3, pp. 792–799, 1996. View at Google Scholar
  13. J H Campbell and G R Campbell, “Phenotypic modulation of smooth muscle cells in primary culture,” in Vascular Smooth Muscle in Culture, J H Campbell and G R Campbell, Eds., CRC Press, Boca Raton, Fla, 1st edition, 1987. View at Google Scholar
  14. A Hurlstone, I A Olave, N Barker, M Van Noort, and H Clevers, “Cloning and characterization of hELD/0SA1, a novel BRG1 interacting protein,” Biochemical Journal, vol. 364, no. 1, pp. 255–264, 2002. View at Google Scholar
  15. G Garin, C Badid, B McGregor et al., “Ischemia induces early expression of a new transcription factor (6A3-5) kidney vascular smooth muscle cells: studies in rat and human renal pathology,” American Journal of Pathology, vol. 163, no. 6, pp. 2485–2494, 2003. View at Google Scholar
  16. F Aguilar, M Lo, B Claustrat, J M Saez, J Sassard, and J Y Li, “Hypersensitivity of the adrenal cortex to trophic and secretory effects of angiotensin II in Lyon genetically-hypertensive rats,” Hypertension, vol. 43, no. 1, pp. 87–93, 2004. View at Publisher · View at Google Scholar
  17. Z Kozmik, O Machoň, J Králová, J Krešlová, J Pačes, and C Vlček, “Characterization of mammalian orthologues of the Drosophila osa gene: cDNA cloning, expression, chromosomal localization, and direct physical interaction with brahma chromatin-remodeling complex,” Genomics, vol. 73, no. 2, pp. 140–148, 2001. View at Publisher · View at Google Scholar
  18. J E Treisman, A Luk, G M Rubin, and U Heberlein, “Eyelid antagonizes wingless signaling during Drosophila development and has homology to the bright family of DNA-binding proteins,” Genes and Development, vol. 11, no. 15, pp. 1949–1962, 1997. View at Google Scholar
  19. C L Peterson and I Herskowitz, “Characterization of the yeast SWI1, SWI2, and SWI3 genes, which encode a global activator of transcription,” Cell, vol. 68, no. 3, pp. 573–583, 1992. View at Publisher · View at Google Scholar
  20. S L Gregory, R D Kortschak, B Kalionis, and R Saint, “Characterization of the dead ringer gene identifies a novel, highly conserved family of sequence-specific DNA-binding proteins,” Molecular and Cellular Biology, vol. 16, no. 3, pp. 792–799, 1996. View at Google Scholar
  21. C F Webb, “The transcription factor, Bright and immunoglobulin heavy chain expression,” Immunologic Research, vol. 24, no. 2, pp. 149–161, 2001. View at Publisher · View at Google Scholar
  22. M Watanabe, M D Layne, C-M Hsieh et al., “Regulation of smooth muscle cell differentiation by AT-rich interaction domain transcription factors Mrf2a and Mrf2ß,” Circulation Research, vol. 91, no. 5, pp. 382–389, 2002. View at Publisher · View at Google Scholar
  23. C M Shanahan and P L Weissberg, “Smooth muscle cell heterogeneity: patterns of gene expression in vascular smooth muscle cells in vitro and in vivo,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 3, pp. 333–338, 1998. View at Google Scholar
  24. N Blaes, M C Bourdillon, J M Daniel-Lamaziere, J J Michaille, M Andujar, and C Covacho, “Isolation of two morphologically distinct cell lines from rat arterial smooth muscle expressing high tumorigenic potentials,” In Vitro Cellular & Developmental Biology, vol. 27, no. 9, pp. 725–734, 1991. View at Google Scholar
  25. H Inoue, T Furukawa, S Giannakopoulos, S Zhou, D S King, and N Tanese, “Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors,” Journal of Biological Chemistry, vol. 277, no. 44, pp. 41674–41685, 2002. View at Publisher · View at Google Scholar
  26. E Van Belle, C Bauters, N Wernert et al., “Angiotensin converting enzyme inhibition prevents proto-oncogene expression in the vascular wall after injury,” Journal of Hypertension, vol. 13, no. 1, pp. 105–112, 1995. View at Publisher · View at Google Scholar
  27. D A Linseman, C W Benjamin, and D A Jones, “Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells,” Journal of Biological Chemistry, vol. 270, no. 21, pp. 12563–12568, 1995. View at Publisher · View at Google Scholar
  28. S Kim, Y Zhan, Y Izumi, H Yasumoto, M Yano, and H Iwao, “In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 12, pp. 2539–2545, 2000. View at Google Scholar
  29. M Vincent and J Sassard, “Lyon strains,” in Textbook of Hypertension, J D Swales, Ed., pp. 455–456, Blackwell, Oxford, UK, 1994. View at Google Scholar
  30. P Lantelme, M Lo, L Luttenauer, and J Sassard, “Pivotal role of the renin-angiotensin system in Lyon hypertensive rats,” American Journal of Physiology, vol. 273, no. 5 pt 2, pp. R1793–R1799, 1997. View at Google Scholar
  31. F C Tanner, H Greutert, C Barandier, K Frischknecht, and T F Lüscher, “Different cell cycle regulation of vascular smooth muscle in genetic hypertension,” Hypertension, vol. 42, no. 2, pp. 184–188, 2003. View at Publisher · View at Google Scholar
  32. A Sabri, B I Levy, P Poitevin et al., “Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 2, pp. 257–264, 1997. View at Google Scholar
  33. N Kaplan-Albuquerque, C Garat, C Desseva, P L Jones, and R A Nemenoff, “Platelet-derived growth factor-BB-mediated activation of Akt suppresses smooth muscle-specific gene expression through inhibition of mitogen-activated protein kinase and redistribution of serum response factor,” Journal of Biological Chemistry, vol. 278, no. 41, pp. 39830–39838, 2003. View at Publisher · View at Google Scholar